Green Synthesized Silver Nanoparticles-Mediated Cytotoxic Effect in Colorectal Cancer Cells: NF-kappa B Signal Induced Apoptosis Through Autophagy
BIOLOGICAL TRACE ELEMENT RESEARCH
Authors: Akter, Mahmuda; Atique Ullah, A. K. M.; Banik, Subrata; Sikder, Md. Tajuddin; Hosokawa, Toshiyuki; Saito, Takeshi; Kurasaki, Masaaki
Abstract
Green synthesized silver nanoparticles (Ag-NPs) have demonstrated promising effects, including cytotoxicity and anticancer potential, in different cell lines. Therefore, in our previous study, Ag-NPs were synthesized from the reduction of AgNO3 using Brassica rapa var. japonica (Bj) leaf extract as a reducing and stabilizing agent. The synthesized Ag-NPs were spherical in shape, with a size range of 15-30 nm. They had phase-centered cubic structure with strong growth inhibition potential against some bacteria. In continuation with our previous study, in the present study, we aimed to investigate the autophagy-regulated cytotoxic effect of Ag-NPs against human epithelial colorectal adenocarcinoma cells (Caco-2 cells). We found that the Bj leaf aqueous extract facilitated Brassica silver nanoparticles (Brassica Ag-NPs)-induced NF-kappa B mediated autophagy in Caco-2 cells. Results showed that Ag-NPs reduced cell viability of Caco-2 cells by inducing oxidative stress and DNA damage. Therefore, to understand the mechanism underlying the death-promoting activity of Ag-NPs in Caco-2 cells, western blotting was performed. Western blot analysis showed decreased expression of NF kappa B and increased expression of I kappa B, which is a sign of autophagy initiation. In addition, autophagosome formation was accelerated by the activity of p53 and light chain 3 (LC3) II. In addition, inhibition of Akt and mTOR also played a pivotal role in autophagy formation. Finally, excessive expansion of autophagy promoted apoptosis, which subsequently resulted in necrosis. These findings support a novel cell death-promoting function of autophagy by Ag-NPs in Caco-2 cells.
Thromboprophylaxis after renal transplantation and patient risk stratification: The case of mTOR inhibitors
THROMBOSIS RESEARCH
Authors: Jara-Palomares, Luis; Solier-Lopez, Aurora; Russo, Mariaconcetta; Suner, Marta; Gonzalez-Roncero, Francisco; Peters-Sengers, Hessel; Middeldorp, Saskia; Bemelman, Frederike J.; Barco, Stefano
Abstract